SAN FRANCISCO, Oct. 7, 2020 -- Quit Genius, the world's first digital clinic for multiple addictions, today announced its partnership with Evernorth, Cigna Corporation's health services segment, to broaden access to its digital addiction solutions. As the single solution for nicotine cessation on the Evernorth Digital Health Formulary, Evernorth clients that utilize Quit Genius will have access to its digital program built on the evidence-based principles of Medication-Assisted Treatment (MAT) to improve quit rates and lower overall healthcare costs, including those exacerbated by the pandemic.
"The social isolation and stress brought on by the pandemic has increased susceptibility to substance abuse, addiction and relapse. As the world continues to navigate the realities of COVID-19, people who smoke or vape, use opioids or have other addiction issues have become part of the more vulnerable population, as direct challenges to respiratory health cause those who smoke to be particularly susceptible to infection by the coronavirus and its associated complications," said Dr. Yusuf Sherwani, Quit Genius Co-Founder and CEO. "Being Evernorth's digital health solution for nicotine cessation is an important step forward in helping those that struggle with addiction gain access to the solutions they need."
"First and foremost, the Digital Health Formulary is focused on creating better individual health outcomes, which is why we offer rigorously evaluated solutions in combination with support from Express Scripts specialist pharmacists," said Mark Bini, chief patient experience officer of Express Scripts. "The added benefit to health plans is the simplicity and affordability we offer by helping navigate the morass of more than 300,000 digital health solutions on the market today, and delivering average plan savings of more than $120,000 per digital solution in alleviated administrative burden alone."
The Evernorth Digital Health Formulary, announced last year, allows participating employers and health plans to increase patients' access to emerging products and technology simply and affordably. Customers who access Quit Genius via the Digital Health Formulary are able to streamline the procurement process while members will receive support from Express Scripts specialist pharmacists to ensure appropriate use of the technology.
Quit Genius is the world's first digital clinic for treating nicotine, alcohol and opioid addictions. Built on the evidence-based practice of Medication-Assisted Treatment (MAT), Quit Genius combines virtual behavioral therapy with approved medication and connected devices to help employers tackle the high cost of addiction in the workplace while improving the lives of their employees. To-date, Quit Genius has helped more than 750,000 people improve their lives and quit their addictions. The company integrates with health plans, pharmacy benefit managers and wellness platforms to deliver a turnkey implementation experience. Visit quitgenius.com for more information.